Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Cancers
|
July 10, 2019
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
Dennie Meijer, R Jeroen A van Moorselaar, André N Vis, et al.
Diagnostics (Basel, Switzerland)
|
January 16, 2021
Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers
Wietske I Luining, Dennie Meijer, Max R Dahele, et al.
Emerging Infectious Diseases
|
December 19, 2018
Zoonotic Endocarditis in a Man, the Netherlands
Janneke Sleutjens, Dennie Meijer, Paola G Meregalli, et al.
Clinical Nuclear Medicine
|
July 31, 2019
18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer
Dennie Meijer, Maurits Wondergem, Remco J J Knol, et al.
Cancers
|
March 10, 2022
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer
Wietske I Luining, Matthijs C F Cysouw, Dennie Meijer, et al.
International Urology and Nephrology
|
August 23, 2022
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study
Noor van Ginkel, Tom J N Hermans, Dennie Meijer, et al.
European Urology Oncology
|
April 26, 2025
Oncological Outcomes in Patients with Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-detected Oligometastatic Prostate Cancer Treated with Metastasis-directed Radiotherapy as the Single Treatment Modality
Katelijne C C de Bie, Lotte G Zuur, Dennie Meijer, et al.
Biomedicines
|
March 29, 2023
Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden
Hans Veerman, Sophia H van der Graaf, Dennie Meijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 25, 2022
Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
Marinus J Hagens, Daniela E Oprea-Lager, André N Vis, et al.
BJU International
|
May 24, 2021
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging
Dennie Meijer, Pim J van Leeuwen, Maarten L Donswijk, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Cancers
|
July 10, 2019
Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
Dennie Meijer, R Jeroen A van Moorselaar, André N Vis, et al.
Diagnostics (Basel, Switzerland)
|
January 16, 2021
Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers
Wietske I Luining, Dennie Meijer, Max R Dahele, et al.
Emerging Infectious Diseases
|
December 19, 2018
Zoonotic Endocarditis in a Man, the Netherlands
Janneke Sleutjens, Dennie Meijer, Paola G Meregalli, et al.
Clinical Nuclear Medicine
|
July 31, 2019
18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer
Dennie Meijer, Maurits Wondergem, Remco J J Knol, et al.
Cancers
|
March 10, 2022
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer
Wietske I Luining, Matthijs C F Cysouw, Dennie Meijer, et al.
International Urology and Nephrology
|
August 23, 2022
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study
Noor van Ginkel, Tom J N Hermans, Dennie Meijer, et al.
European Urology Oncology
|
April 26, 2025
Oncological Outcomes in Patients with Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-detected Oligometastatic Prostate Cancer Treated with Metastasis-directed Radiotherapy as the Single Treatment Modality
Katelijne C C de Bie, Lotte G Zuur, Dennie Meijer, et al.
Biomedicines
|
March 29, 2023
Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden
Hans Veerman, Sophia H van der Graaf, Dennie Meijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 25, 2022
Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
Marinus J Hagens, Daniela E Oprea-Lager, André N Vis, et al.
BJU International
|
May 24, 2021
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging
Dennie Meijer, Pim J van Leeuwen, Maarten L Donswijk, et al.
Page
of 4